A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This was a randomized, double-blind, placebo-controlled, multicentre, phase 2 study to evaluate the efficacy, safety and tolerability of orally administered EDP-938 in adults with RSV infection.
Epistemonikos ID: 8a2d0418208e167541ea76a191e94201947dc386
First added on: Mar 23, 2020